JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gasior, M.
Right arrow Articles by Witkin, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gasior, M.
Right arrow Articles by Witkin, J. M.

Vol. 295, Issue 1, 153-161, October 2000

Chlormethiazole: Effectiveness against Toxic Effects of Cocaine in Mice1

Maciej Gasior2, Jesse T. Ungard3 and Jeffrey M. Witkin

Drug Development Group, Behavioral Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland

Chlormethiazole positively modulates the gamma -aminobutyric acid (GABA)A receptor complex and is primarily used to treat certain life-threatening neurological events (e.g., refractory seizures and ethanol withdrawal syndrome). On account of several experimental and clinical studies reporting effectiveness against the toxic effects of heroin and methamphetamine, chlormethiazole was systematically tested in the present study for its effectiveness against cocaine-induced seizures and lethality in mice. The protective effects of chlormethiazole were evaluated against single, submaximal convulsive (75 mg/kg) or lethal (110 mg/kg) doses of cocaine. Chlormethiazole also was tested against the expression (anticonvulsant effect) and development (antiepileptogenic effect) of cocaine-kindled seizures, and against fully developed kindled seizures. Cocaine-kindled seizures were produced by a total of five daily treatments with 60 mg/kg cocaine. The inverted-screen test was used to assess behavioral side effects of chlormethiazole. Chlormethiazole protected against acute cocaine-induced convulsions (ED50 = 7.0 mg/kg) and lethality (ED50= 21.8 mg/kg) with a robust separation [protective index (PI) = TD50/ED50 = 22.3 and 7.2, respectively] from doses producing behavioral side effects (TD50 = 156 mg/kg). Chlormethiazole suppressed the behavioral expression of cocaine-kindled seizures and prevented the development of sensitization to the convulsant effects of cocaine. It was also effective in suppressing fully developed kindled seizures. Relative to cocaine seizures in naive mice, chlormethiazole was equieffective, less potent (ED50 = 22.3 mg/kg), and had a reduced protective index (PI = 3.7) against cocaine-induced seizures in kindled mice. The protective profile and protective index of chlormethiazole were superior to those of the benzodiazepines clonazepam and diazepam, which were of limited efficacy and had low protective indices (PI = ~1). The results of this study predict the potential utility of chlormethiazole for the treatment of life-threatening complications of cocaine abuse for which no specific treatment has yet been identified.


1 Preliminary findings of this study were presented at the American Society for Pharmacology and Experimental Therapeutics Meeting, Boston, MA, June 4-8, 2000.

2 M.G. was a Visiting Fellow in the National Institutes of Health Visiting Program granted from the Fogarty International Center, Bethesda, MD. Permanent affiliation: Department of Pharmacology, Medical University School, Lublin, Poland. Current address: Department of Psychiatry, Behavioral Pharmacology Program, McLean Hospital, Harvard Medical School, Belmont, MA 02178.

3 Present address: Department of Psychiatry, Johns Hopkins University, School of Medicine, Baltimore, MD 21224.


0022-3565/00/2951-0153$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by U.S. Government



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M.-C. Ko, L. D. Bowen, D. Narasimhan, A. A. Berlin, N. W. Lukacs, R. K. Sunahara, Z. D. Cooper, and J. H. Woods
Cocaine Esterase: Interactions with Cocaine and Immune Responses in Mice
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 926 - 933.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.